阿司匹林辅助治疗进展性脑梗死的临床疗效探讨  

Clinical Efficacy of Aspirin in the Treatment of Progressive Cerebral Infarction

作　　者：关毓岫 陈兵[2] Guan Yuxiu;Chen Bing(Jiamusi University,Jiamusi 154007;The Eighth Medical Center of PLA General Hospital,Beijing 100089,China)

机构地区：[1]佳木斯大学,黑龙江佳木斯154007 [2]解放军总医院第八医学中心,北京100089

出　　处：《广东化工》2021年第7期49-49,27,共2页Guangdong Chemical Industry

摘　　要：目的:研究阿司匹林在辅助治疗进展性脑梗死患者中的临床疗效。方法:选择我院于2019年3月~2020年8月间收治的74例进展性脑梗死患者,根据入院顺序平均分组后,对照组患者接受常规治疗,实验组患者则在常规干预的基础上联合接受阿司匹林治疗,比较两组进展性脑梗死患者的临床治疗效果。结果:进展性脑梗死患者的治疗效果显示,实验组显著高于对照组(P<0.05);两组患者干预后不良反应比较,数据差异无统计学意义(P>0.05)。结论:在进展性脑梗死患者临床治疗中,使用阿司匹林辅助治疗的能够进一步改善患者临床症状,是一种科学手段。Objective: To study the clinical efficacy of aspirin in the adjuvant treatment of patients with progressive cerebral infarction. Methods: 74 patients with progressive cerebral infarction admitted to our hospital from March 2019 to August 2020 were divided into two groups according to the order of admission. The control group received conventional treatment, while the experimental group received aspirin on the basis of conventional intervention. Results: the treatment effect of patients with progressive cerebral infarction showed that the experimental group was significantly higher than that of the control group(P<0.05);there was no significant difference in adverse reactions between the two groups(P>0.05). Conclusion: in the clinical treatment of patients with progressive cerebral infarction, the use of aspirin adjuvant therapy can further improve the clinical symptoms of patients, is a scientific means.

关 键 词：进展性脑梗死 阿司匹林 治疗效果 不良反应 

分 类 号：TQ[化学工程]